Middle Country Family Medicine

Newsflash

Welcome To
Middle Country Family Medicine Website.

We Hope You Find
The Website Useful

Flu Season is Upon Us....
Don't forget to schedule an
appointment for a flu shot.

A federal panel recommended Wednesday that all children get an annual flu shot, dramatically expanding the pool of people who are urged to ward off the contagious respiratory illness -- and possibly paving the way for a universal flu shot recommendation.

The Advisory Committee on Immunization Practices, which makes recommendations to the Centers for Disease Control and Prevention, expanded the group of children who should get annual flu shots to include healthy children ages 5-18. Previously, the recommendation included only those 6 months to age 5.

Main Menu

Patient Information

Bookmark Us

Contact Information

Dr. Michael Randall
2539 Middle Country Road
Centereach, New York 11720
Tel: (631)580-1740
Fax: (631)580-9155

:: Contact Us ::
:: Directions ::

Plan route with GMaps

Plan your route to us

Visitors Counter

Visitors Counter 1.0.2

Home

Medical News

Medical News
ADHD News From Medical News Today
Latest Health News and Medical News posted throughout the day, every day.
Actavis Receives FDA Approval Of Atomoxetine HCl Capsules Actavis has received approval from the U.S. Food & Drug Administration to market Atomoxetine HCl capsules for the treatment of attention deficit/hyperactivity disorder (ADHD). Actavis intends to market Atomoxetine HCl in 10 mg, 18 mg, 25 mg, 40 mg, 60 mg, 80 mg and 100 mg strengths... Sun Pharma Announces USFDA Approval For Generic Strattera(R) Capsules Sun Pharmaceutical Industries Ltd. (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE:SUNPHARMA, BSE: 524715) announced that USFDA has granted its subsidiary an approval for its Abbreviated New Drug Application (ANDA) to market a generic version of Strattera ®, atomoxetine hydrochloride capsules... Cognitive Behavioral Therapy Appears Beneficial For Adults With ADHD Adults with attention-deficit/hyperactivity disorder (ADHD) who received medication and individual sessions of cognitive behavioral therapy (CBT) showed greater improvement in symptoms through 12 months compared to patients who did not receive CBT, according to a study in the August 25 issue of JAMA. "Approximately 4... Cognitive Behavior Therapy Improves Symptom Control In Adult ADHD Adding cognitive behavioral therapy -- an approach that teaches skills for handling life challenges and revising negative thought patterns -- to pharmaceutical treatment for attention-deficit hyperactivity disorder (ADHD) significantly improved symptom control in a study of adult patients... Cognitive Behavioral Therapy Plus Medication Better Than Medication Alone For ADHD Adult Patients An adult with attention-deficit/hyperactivity disorder (ADHD) who takes targeted medication combined with 1-on-1 sessions of CBT (cognitive behavioral therapy) is likely to experience significantly greater improvement of symptoms compared to an ADHD adult patient who only has the medication, according to research published in JAMA (Journal of the American Medical Association), August 25th issue... New ADHD Study Shows The Potential Efficacy Of New Multi-Modal Hemispheric Based Program In Boosting Academic And Cognitive Performance Of Children A new ADD/ADHD study found that a multi-modal hemispheric based program significantly improved the participant's educational outcomes... Curemark To Present At BioPharm America? 2010 Curemark, LLC, a drug research and development company focused on the treatment of neurological diseases, will present at BioPharm America? 2010, to be held September 15-17 in Boston at the Marriott Boston Copley Place, the company announced. Dr. Joan Fallon, Curemark's founder and CEO, will provide an overview of the company's enzyme replacement therapy targeted to autism... Pesticides May Be Contributing To ADHD And Adversely Affecting Brain Development A baby is more likely to suffer from ADHD (attention deficit/hyperactivity disorder) while it is still in the womb if the mother is exposed to organophosphate (OP) pesticides, according to a new study published in Environmental Health Perspectives. Over the last few years there has been increasing interest in determining whether OP pesticides might undermine brain development...

Medical News Updates

Clinical Trials / Drug Trials News From Medical News Today
Latest Health News and Medical News posted throughout the day, every day.

Abiraterone Acetate For Metatastic Prostate Cancer So Effective That Phase 3 Trial Was Unblinded
Abiraterone Acetate plus prednisone was undergoing Phase 3 clinical trials on patients with metastatic advanced prostate cancer (castration-resistant prostate cancer) when an Independent Data Monitoring Committee recommended unblinding the study - this means the patients who were not receiving the Abiraterone Acetate should be offered it, Ortho Biotech Oncology Research & Devel...

Improving Drug Therapy Using Gene Profiles
The National Institute of General Medical Sciences has awarded a $9.1 million, five-year grant to The Ohio State University for a study titled "Expression Genetics in Drug Therapy." The goal of the research is to enhance drug response rates and reduce the number of adverse drug reactions among patients taking medication...

Tragara Pharmaceuticals Initiates Phase I Clinical Program For TG02
Tragara Pharmaceuticals, Inc. announced the initiation of a phase I clinical trial of TG02, a unique oral multi-kinase inhibitor, in patients with advanced/refractory hematologic malignancies. Tragara will conduct the study at multiple clinical centers in the United States...

Cempra Pharmaceuticals Presents New Data On TAKSTA? (CEM-102, Sodium Fusidate) At The 50th Interscience Conference
Cempra Pharmaceuticals announced abstracts to be presented on its oral anti-MRSA antibiotic, TAKSTA (sodium fusidate, formerly CEM-102), at the 50th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), September 12 to 15, 2010, in Boston. Data to be presented demonstrate that TAKSTA showed clinical success rates and tolerability comparable to oral linezolid...

Terumo Medical Corporation Announces First U.S. Patient Implant In Landmark Pilot Study Simultaneously Enrolling In The U.S. & Japan
Terumo Medical Corporation, a U.S.-based subsidiary of Terumo Corporation, announced the first U.S. patient implant in the Occlusive/Stenotic Peripheral artery Revascularization Study (OSPREY), which will evaluate the safety and efficacy of its MISAGO? Peripheral Self-expanding Stent System for use in the superficial femoral artery (SFA)...

European Medicines Agency Holds International Workshop On Clinical Trials In The Context Of Global Medicines Development
Participants from around the world emphasise the need for cooperation to ensure a robust global framework for clinical trials On 6-7 September 2010 the European Medicines Agency (EMA) held an international workshop with a broad cross section of stakeholders from around the world to discuss a way forward for a global framework of clinical trials that has at its heart the prot...

First Patient Enrolled In 'CONNECT' Clinical Trial
Avinger, Inc., a medical device company focused on the development of innovative devices to combat peripheral artery disease, announces the enrollment of the first patient in the CONNECT (Chronic TOtal OcclusioN CrossiNg with thE WildCat CatheTer) clinical trial...

Study Of Investigational Agent Abiraterone Acetate For Metastatic Advanced Prostate Cancer Unblinded After Meeting Pre-Determined Criteria
Ortho Biotech Oncology Research & Development, a unit of Cougar Biotechnology, Inc...